JUL 16, 2026 · REGULATORY LABEL UPDATE
FDA supplemental approval: Neupogen (Labeling)
U.S. Food and Drug Administration
FDA supplemental approval for labeling changes to an established drug; does not report clinical trial data or efficacy evidence.
Reported
Approval date2026-07-16